Join the Vaccination and Prophlaxis group to help and get support from people like you.
Vaccination and Prophlaxis News (Page 15)
One-Dose MVA-BN Vaccine Moderately Effective Against Mpox
TUESDAY, Sept. 17, 2024 – One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities, according to a study published...
Expert Advice on Preparing for the Fall COVID, Flu Season
MONDAY, Sept. 16, 2024 – People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says. “When my patients ask m...
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
THURSDAY, Sept. 12, 2024 – A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the p...
Stopping a Bird Flu Epidemic: What Experts Say Must Be Done
MONDAY, Sept. 9, 2024 – The time is now to prepare for a potential pandemic involving the H5N1 bird flu, says a group of international vaccine and public health experts. Avian influenza vaccines...
FDA Approves New Fully Liquid Presentation of GSK’s Rotarix Vaccine to Prevent Gastroenteritis Caused by Rotavirus
New fully liquid formulation of Rotarix removes the need to reconstitute prior to administration, for improved convenience Clinical data demonstrated non-inferiority of immunogenicity as compared to...
Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles
London UK 20 October 2017 – GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age
SWIFTWATER, Pa., March 25, 2015 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi , announced today that the U.S. Food and Drug Administration (FDA) has approved use of Quadracel...